Our results for p16 protein expression in 50 HNSCC cases showed that 42% (21/50) were positive for p16 over-expression (Figure 5, sample A), including all the 10 HPV-positive tumors (double-positive). The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.